Login or sign up
For business

Catapult Therapeutics

4.0ยท 12 reviews
Average ratingGreat
4.0/ 5

Based on 12 reviews

533%
433%
333%
20%
10%
Ask AI

Ask AI about Catapult Therapeutics

Generated with AI from 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Catapult Therapeutics

Catapult Therapeutics is a privately held Dutch biotech company developing CAP-100 โ€“ an innovative first-in-class humanized anti-CCR7 antibody.

The chemokine receptor CCR7 is over-expressed in many cancers, and high CCR7 expression is associated with poor prognosis and short survival in hematological and solid malignancies. Preclinical studies have shown that the anti-CCR7 antibody can prolong survival and inhibit cancer cell migration in multiple animal models of B-cell and T-cell lymphomas.